Aurobindo Pharma Limited (AUROPHARMA.BO)

1,087.10 -27.80 (-2.49%) At close: 03:52PM IST

Aurobindo Pharma Limited

Galaxy, Plot No. 1
22nd-24th Floor Plot No.1, Survey No.83/1 Hyderabad Knowledge City,Raidurg Panmakt
Hyderabad 500032
India
91 40 6672 5000
https://www.aurobindo.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 23,451

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kambam Nityananda Reddy	Vice Chairman & MD	37.41M	N/A	1958
Mr. Mettu Madan Mohan Reddy	Whole-Time Director	52.35M	N/A	1960
Mr. Santhanam Subramanian	Chief Financial Officer	21.06M	N/A	1961
Mr. Sanjeev Indravadan Dani	COO & Head of Formulations	N/A	N/A	1960
Mr. Arvind Bothra	Head of Investor Relations & Corporate Communications	N/A	N/A	N/A
Mr. B. Adi Reddy	Compliance Officer & Company Secretary	4.76M	N/A	N/A
Mr. G. P. Prasad	Senior Vice President of Global Finance & Operations	N/A	N/A	N/A
Dr. Sudhir Bimal Singhi	Head of Global Finance Operations	N/A	N/A	1969
Dr. A. Rama Mohana Rao	President of Corporate QA	N/A	N/A	1962
Dr. V. K. Handa	President of Chemical Research	N/A	N/A	1952

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Corporate governance

Aurobindo Pharma Limited’s ISS governance QualityScore as of 1 April 2024 is 4. The pillar scores are Audit: 5; Board: 8; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.